Evodiamine as a novel antagonist of aryl hydrocarbon receptor

Biochemical and Biophysical Research Communications

Volumn 402, Issue 1, 2010, Pages 94-98

  Yu, Hui ^a,b   Tu, Yongjiu ^a   Zhang, Chun ^a   Fan, Xia ^a   Wang, Xi ^a   Wang, Zhanli ^c   Liang, Huaping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Antagonist; Aryl hydrocarbon receptor; Docking; Evodiamine; Homology modeling

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOSOL RECEPTOR; EVODIAMINE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIVER CYTOSOL; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CYTOCHROME P-450 CYP1A1; GENE EXPRESSION; HUMANS; MODELS, MOLECULAR; PLANT EXTRACTS; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; QUINAZOLINES; RATS; RECEPTORS, ARYL HYDROCARBON;

CITRUS MAXIMA;

EID: 78049278823     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.122     Document Type: Article

References (21)

1. Kano Y., Zong Q., Komatsu K. Pharmacological properties of galenical preparation. XIV. Body temperature retaining effect the Chinese traditional medicine, ''Goshuyu-to'' and component crude drugs. Chem. Pharm. Bull. 1991, 39:690-692.
2. Fei X.F., Wang B.X., Li T.J., Yashiro S., Minami M., Xing D.J., Ikejima T. Evodiamine, a constituent of evodiae fructus, induces antiproliferating effects in tumor cells. Cancer Sci. 2003, 94:92-98.
3. Hahn M.E. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. 1998, 121:23-53.
4. Sinal C.J., Bend R.J. Aryl hydrocarbon receptor-dependent induction of Cyp1a1 by bilirubin in mouse hepatatoma hepa 1c1c7 cells. Mol. Pharmacol. 1997, 52:590-599.
5. Heath-Pagliuso S., Rogers W.J., Tullis K., Seidel S.D., Cenijn P.H., Brouwer A., Denison M.S. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 1998, 37:11508-11515.
6. Kawajiri K., Fujii-Kuriyama Y. Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Arch. Biochem. Biophys. 2007, 464:207-212.
7. Brauze D., Widerak M., Cwykiel J., Szyfter K., Baer-Dubowska W. The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. Toxicol. Lett. 2006, 167:212-220.
8. Rushmore T.H., King R.G., Paulson E.K., Pickett C.B. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA 1990, 87:3826-3832.
9. Iyanagi T., Haniu M., Sogawa K., Fujii-Kuriyama Y., Watanabe S., Shively J.E., Anan K.F. Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J. Biol. Chem. 1986, 261:15607-15614.
10. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
11. Gasiewicz T.A., Kende A.S., Rucci G., Whitney B., Willey J. Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. Biochem. Pharmacol. 1996, 52:1787-1803.
12. Henry E.C., Kende A.S., Rucci G., Totleben M.J., Willey J., Dertinger S.D., Pollenz R.S., Jones J.P., Gasiewicz T.A. Flavone antagonists bind competitively with 2,3,7,8-tetrachlorodibenzo-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol. Pharmacol. 1999, 55:716-725.
13. Zhou J.-G., Henry E.C., Palermo C.M., Dertinger S.D., Gasiewicz T.A. Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements. Mol. Pharmacol. 2003, 63:915-924.
14. Kim S.-H., Henry E.C., Kim D.-K., Kim Y.-H., Shin K.J., Han M.S., Lee T.G., Kang J.-K., Gasiewicz T.A., Ryu S.H., Suh P.-G. Novel compound 2-methyl-2 -pyrazole-3-carboxylic acid (2-methyl-4-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 2006, 69:1871-1878.
15. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389:753-758.
16. Thompson J., Higgins D., Gibson T. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nuc. Acid Res. 1994, 22:4673-4680.
17. Hartshorn M.J., Verdonk M.L., Chessari G., Brewerton S.C.W., Mooij T.M., Mortenson P.N., Murray C.W. Diverse, high-quality test set for the validation of protein-ligand docking performance. J. Med. Chem. 2007, 50:726-741.
18. Ashida H., Fukuda I., Yamashita T., Kanazawa K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett. 2000, 476:213-217.
19. Liu H., Santostefano M., Lu Y., Safe S. 6-substituted 3,4-benzocoumarins: a new structural class of inducers and inhibitors of CYP1A1-dependent activity. Arch. Biochem. Biophys. 1993, 306:223-231.
20. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22:3099-3108.
21. Bisson W.H., Koch D.C., O'Donnell E.F., Khalil S.M., Kerkvliet N.I., Tanguay R.L., Abagyan R., Kolluri S.K. Modeling of the aryl hydrocarbon receptor (AhR) ligand binding domain and its utility in virtual ligand screening to predict new AhR ligands. J. Med. Chem. 2009, 52:5635-5641.